Status:
COMPLETED
Quality Improvement in Stroke Prevention (QUISP)
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Kaiser Permanente
Conditions:
Ischemic Stroke
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
Is a secondary prevention intervention, focused on implementation of standardized pre-printed discharge orders for hospitalists, effective at increasing utilization of the following evidence-based tre...
Detailed Description
There are several proven strategies for prevention of recurrent ischemic stroke, including use of statins, treatment of hypertension, and anticoagulation in patients with atrial fibrillation. Prelimin...
Eligibility Criteria
Inclusion
- Ischemic stroke Kaiser-Permanente Health Plan Member with Pharmacy Benefit Discharged alive to home
Exclusion
- tpA patients Hemorrhagic stroke TIA Significant comorbidities
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00328640
Start Date
December 1 2005
End Date
March 1 2007
Last Update
April 27 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser-Permanente Division of Research
Oakland, California, United States, 94612